Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice

Chien-Fu Hung, Y. C. Tsai, L. He, G. Coukos, I. Fodor, L. Qin, H. Levitsky, Tzyy Choou Wu

Research output: Contribution to journalArticle

Abstract

Vaccinia virus has been shown to efficiently infect tumor cells. Therefore, vaccinia virus represents a potentially safe and effective antitumor agent against ovarian cancer. Here, we assessed the ability of vaccinia virus to preferentially infect and control both human and murine ovarian tumors in vivo. We used the non-invasive luminescence imaging system to monitor the infection and suppression of ovarian tumors by vaccinia in live mice. Our data indicated that vaccinia was able to effectively infect and kill both human and murine ovarian tumors. Vaccinia virus administered to mice intraperitoneally was specifically targeted to the murine or human ovarian tumors and led to antitumor responses. These findings suggest that vaccinia virus is capable of selectively targeting and controlling ovarian tumors. Thus, intraperitoneal injection with vaccinia virus may provide a potentially effective strategy for treating advanced-stage ovarian cancers.

Original languageEnglish (US)
Pages (from-to)20-29
Number of pages10
JournalGene Therapy
Volume14
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Vaccinia virus
Vaccinia
Neoplasms
Ovarian Neoplasms
Luminescence
Intraperitoneal Injections
Antineoplastic Agents
Infection

Keywords

  • Antitumor effects
  • Luciferase
  • Ovarian cancer
  • Vaccinia virus

ASJC Scopus subject areas

  • Genetics

Cite this

Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice. / Hung, Chien-Fu; Tsai, Y. C.; He, L.; Coukos, G.; Fodor, I.; Qin, L.; Levitsky, H.; Wu, Tzyy Choou.

In: Gene Therapy, Vol. 14, No. 1, 01.2007, p. 20-29.

Research output: Contribution to journalArticle

Hung, Chien-Fu ; Tsai, Y. C. ; He, L. ; Coukos, G. ; Fodor, I. ; Qin, L. ; Levitsky, H. ; Wu, Tzyy Choou. / Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice. In: Gene Therapy. 2007 ; Vol. 14, No. 1. pp. 20-29.
@article{c73c25e6d817433081c8e4085ddcb472,
title = "Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice",
abstract = "Vaccinia virus has been shown to efficiently infect tumor cells. Therefore, vaccinia virus represents a potentially safe and effective antitumor agent against ovarian cancer. Here, we assessed the ability of vaccinia virus to preferentially infect and control both human and murine ovarian tumors in vivo. We used the non-invasive luminescence imaging system to monitor the infection and suppression of ovarian tumors by vaccinia in live mice. Our data indicated that vaccinia was able to effectively infect and kill both human and murine ovarian tumors. Vaccinia virus administered to mice intraperitoneally was specifically targeted to the murine or human ovarian tumors and led to antitumor responses. These findings suggest that vaccinia virus is capable of selectively targeting and controlling ovarian tumors. Thus, intraperitoneal injection with vaccinia virus may provide a potentially effective strategy for treating advanced-stage ovarian cancers.",
keywords = "Antitumor effects, Luciferase, Ovarian cancer, Vaccinia virus",
author = "Chien-Fu Hung and Tsai, {Y. C.} and L. He and G. Coukos and I. Fodor and L. Qin and H. Levitsky and Wu, {Tzyy Choou}",
year = "2007",
month = "1",
doi = "10.1038/sj.gt.3302840",
language = "English (US)",
volume = "14",
pages = "20--29",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice

AU - Hung, Chien-Fu

AU - Tsai, Y. C.

AU - He, L.

AU - Coukos, G.

AU - Fodor, I.

AU - Qin, L.

AU - Levitsky, H.

AU - Wu, Tzyy Choou

PY - 2007/1

Y1 - 2007/1

N2 - Vaccinia virus has been shown to efficiently infect tumor cells. Therefore, vaccinia virus represents a potentially safe and effective antitumor agent against ovarian cancer. Here, we assessed the ability of vaccinia virus to preferentially infect and control both human and murine ovarian tumors in vivo. We used the non-invasive luminescence imaging system to monitor the infection and suppression of ovarian tumors by vaccinia in live mice. Our data indicated that vaccinia was able to effectively infect and kill both human and murine ovarian tumors. Vaccinia virus administered to mice intraperitoneally was specifically targeted to the murine or human ovarian tumors and led to antitumor responses. These findings suggest that vaccinia virus is capable of selectively targeting and controlling ovarian tumors. Thus, intraperitoneal injection with vaccinia virus may provide a potentially effective strategy for treating advanced-stage ovarian cancers.

AB - Vaccinia virus has been shown to efficiently infect tumor cells. Therefore, vaccinia virus represents a potentially safe and effective antitumor agent against ovarian cancer. Here, we assessed the ability of vaccinia virus to preferentially infect and control both human and murine ovarian tumors in vivo. We used the non-invasive luminescence imaging system to monitor the infection and suppression of ovarian tumors by vaccinia in live mice. Our data indicated that vaccinia was able to effectively infect and kill both human and murine ovarian tumors. Vaccinia virus administered to mice intraperitoneally was specifically targeted to the murine or human ovarian tumors and led to antitumor responses. These findings suggest that vaccinia virus is capable of selectively targeting and controlling ovarian tumors. Thus, intraperitoneal injection with vaccinia virus may provide a potentially effective strategy for treating advanced-stage ovarian cancers.

KW - Antitumor effects

KW - Luciferase

KW - Ovarian cancer

KW - Vaccinia virus

UR - http://www.scopus.com/inward/record.url?scp=33845665403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845665403&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3302840

DO - 10.1038/sj.gt.3302840

M3 - Article

C2 - 16915291

AN - SCOPUS:33845665403

VL - 14

SP - 20

EP - 29

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 1

ER -